Blackstone Inc. (BX) 13D/13G Filings for Autolus Therapeutics plc (AUTL)

Blackstone Inc. 13D and 13G filings for Autolus Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-05-21
4:30 pm
Unchanged
2024-05-17 13D Autolus Therapeutics plc
AUTL
Blackstone Inc.
BX
23,750,917
8.800%
0
(Unchanged)
Filing
2022-12-13
4:51 pm
Purchase
2022-12-08 13D Autolus Therapeutics plc
AUTL
Blackstone Inc.
BX
23,750,917
14.000%
2,500,000increase
(+11.76%)
Filing
2021-11-16
4:07 pm
Purchase
2021-11-06 13D Autolus Therapeutics plc
AUTL
Blackstone Inc.
BX
21,250,917
22.600%
21,250,917increase
(New Position)
Filing